These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3002678

  • 1. The CRFs and their control: chemistry, physiology and clinical implications.
    Gillies G, Grossman A.
    Clin Endocrinol Metab; 1985 Nov; 14(4):821-43. PubMed ID: 3002678
    [Abstract] [Full Text] [Related]

  • 2. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K.
    Acta Neurochir (Wien); 1985 Nov; 75(1-4):49-59. PubMed ID: 2986422
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA, Stalla GK, von Werder K.
    Horm Res; 1987 Nov; 25(4):185-98. PubMed ID: 3034758
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
    Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL.
    Am J Psychiatry; 1984 May; 141(5):619-27. PubMed ID: 6324597
    [Abstract] [Full Text] [Related]

  • 7. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N, Grossman A, Perry L, Tomlin S, Wass JA, Coy DH, Schally AV, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
    [Abstract] [Full Text] [Related]

  • 8. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K.
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [Abstract] [Full Text] [Related]

  • 9. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [Abstract] [Full Text] [Related]

  • 10. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN, Shibasaki T, Suda T, Ling N, Shizume K.
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [Abstract] [Full Text] [Related]

  • 11. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 15. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis.
    Müller OA, Dörr HG, Hagen B, Stalla GK, von Werder K.
    Klin Wochenschr; 1982 Dec 15; 60(24):1485-91. PubMed ID: 6300509
    [Abstract] [Full Text] [Related]

  • 17. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice.
    Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W.
    Endocrinology; 1992 Jun 15; 130(6):3378-86. PubMed ID: 1597149
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct 15; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.